Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R21 NS102829)
U.S. Department of Defense (AL160057)
National Institutes of Health (U54 NS090291, R01 NS088689)
Received: 17 July 2019
Accepted: 13 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: Induced pluripotent stem cells were derived from the blood of consenting individuals within our C9ORF2-ALS patient population under IRB approved protocols at the University of Miami Miller School of Medicine.
: Not Applicable.
: The authors declare that they have no competing interests.